Page last updated: 2024-11-06

3-bromophenylsuccinimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID65706
CHEMBL ID2107507
SCHEMBL ID2109189
MeSH IDM0042874

Synonyms (30)

Synonym
brosuximidum [inn-latin]
brosuximida [inn-spanish]
brosuximide [inn]
2-(m-bromophenyl)succinimide
3-bromophenylsuccinimide
imid kwasu 3-bromofenylobursztynowego [polish]
2,5-pyrrolidinedione, 3-(3-bromophenyl)-
brn 1457286
brosuximide
m-bromophenylsuccinimide
succinimide, 2-(m-bromophenyl)-
3-(3-bromophenyl)-2,5-pyrrolidinedione
3-(3-bromophenyl)pyrrolidine-2,5-dione
brosuximida
22855-57-8
brosuximidum
unii-mh88d3n73w
imid kwasu 3-bromofenylobursztynowego
mh88d3n73w ,
CHEMBL2107507
(+/-)-brosuximide
brosuximide, (+/-)-
AKOS022316994
SCHEMBL2109189
rehmaglutind
DTXSID20865072
Q27284032
2,5-pyrrolidinedione, 3-(3-bromophenyl)- (9ci)
EN300-204682
Z1269180050
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]